PolyNovo Limited Stock
Stocks
PNV
AU000000PNV0
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Australian S.E.
12:10:10 2026-11-11 am EST
|
5-day change | 1st Jan Change | ||
| 0.9050 AUD | +2.26% |
|
-2.16% | -26.42% |
| Oct. 30 | PolyNovo Limited - Shareholder/Analyst Call | |
| Oct. 19 | PolyNovo CFO to Step Down | MT |
| Market Cap | 625M 428M 386M 357M 323M 610M 40.18B 4.28B 1.7B 21.52B 1.61B 1.57B 68.49B | P/E 2027 * |
64.2x | P/E 2028 * | 33.8x |
|---|---|---|---|---|---|
| Enterprise Value | 585M 401M 361M 334M 302M 571M 37.61B 4B 1.59B 20.14B 1.5B 1.47B 64.1B | EV / Sales 2027 * |
3.62x | EV / Sales 2028 * | 3.07x |
| Free-Float |
90.03% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PNV | Delayed | |
OTC Markets
| CALZF | Delayed | |
|
Tradegate
| MFJ | Real-time | |
|
Deutsche Boerse AG
| MFJ | Delayed | |
|
Börse Stuttgart
| MFJ | Delayed | |
|
Boerse Muenchen
| MFJ | Real-time | |
|
Berne S.E.
| MFJ | End-of-day quote |
Last Transcript: PolyNovo Limited
| 25-08-25 | Morgans rates PNV as Speculative Buy | AQ |
| 24-11-25 | Morgans rates PNV as Add | AQ |
| 23-12-07 | Ord Minnett rates PNV as Lighten | AQ |
| 22-04-22 | PolyNovo : Notification regarding unquoted securities - PNV | PU |
| 22-01-23 | PolyNovo : Application for quotation of securities - PNV | PU |
| 1 day | +2.26% | ||
| 1 week | -2.16% | ||
| 1 month | -3.21% | ||
| 3 months | -4.23% | ||
| 6 months | -10.40% | ||
| Current year | -26.42% |
| 1 week | 0.88 |  | 0.94 |
| 1 month | 0.84 | | 0.96 |
| Current year | 0.81 | | 1.3 |
| 1 year | 0.81 | | 1.3 |
| 3 years | 0.81 | | 2.78 |
| 5 years | 0.81 | | 2.78 |
| 10 years | 0.17 | | 4.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Peatey
CEO | Chief Executive Officer | - | 2025-11-30 |
| Director of Finance/CFO | - | 2018-12-11 | |
Marthe D’Ombrain
CTO | Chief Tech/Sci/R&D Officer | - | 2026-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Leon Hoare
CHM | Chairman | - | 2025-10-26 |
Andrew Lumsden
BRD | Director/Board Member | 48 | 2021-06-03 |
Rob Douglas
BRD | Director/Board Member | 66 | 2025-10-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/16/26 | Buy | Director | 151,000 | 0.0219% | ||
| 2/27/26 | Buy | Director | 100,000 | 0.0145% | ||
| 2/27/26 | Buy | Chairman | 30,000 | 0.0043% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.26% | -2.16% | -26.12% | -34.18% | 419M | |
| -0.38% | -4.80% | -13.42% | +14.79% | 191B | |
| -0.62% | -3.73% | +5.92% | +40.19% | 124B | |
| -1.93% | -6.04% | -12.26% | +13.23% | 123B | |
| -2.69% | -3.46% | -42.12% | +3.28% | 96.14B | |
| -0.40% | -1.88% | -4.86% | +74.65% | 66.54B | |
| -0.34% | +1.25% | +12.06% | -10.20% | 57.91B | |
| +0.04% | -0.01% | -1.96% | +61.54% | 54.89B | |
| +1.47% | -3.69% | -4.56% | +55.85% | 49.1B | |
| -3.88% | -6.01% | -3.60% | -9.36% | 36.19B | |
| Average | -0.70% | +1.72% | -9.09% | +20.98% | 80B | |
| Weighted average by Cap. | -0.97% | +2.37% | -9.36% | +24.89% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 162M 111M 99.92M 92.31M 83.45M 158M 10.4B 1.11B 441M 5.57B 416M 407M 17.72B | 186M 127M 115M 106M 95.79M 181M 11.93B 1.27B 506M 6.39B 478M 467M 20.34B |
| Net income | 9.77M 6.7M 6.04M 5.58M 5.04M 9.54M 628M 66.83M 26.64M 336M 25.13M 24.6M 1.07B | 18.5M 12.68M 11.42M 10.55M 9.54M 18.05M 1.19B 126M 50.42M 637M 47.57M 46.56M 2.03B |
| Net Debt | -40.06M -27.45M -24.74M -22.86M -20.66M -39.09M -2.57B -274M -109M -1.38B -103M -101M -4.39B | -55.32M -37.91M -34.17M -31.57M -28.54M -53.99M -3.56B -378M -151M -1.9B -142M -139M -6.06B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-11 | A$0.9050 | +2.26% | 640,882 |
| 26-11-10 | A$0.8850 | -2.75% | 968,354 |
| 26-11-09 | A$0.9100 | +2.25% | 488,618 |
| 26-11-06 | A$0.8900 | -1.66% | 1,062,626 |
| 26-11-05 | A$0.9050 | +3.43% | 1,524,680 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PNV Stock
Select your edition
All financial news and data tailored to specific country editions
